CIBC Asset Management
DNA icon

CIBC Asset Management’s Ginkgo Bioworks DNA Stock Holding History

CIBC Asset Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,139
Closed -$15.2K – 1216
2024
Q2 		$15.2K Buy
1,139
+511
+81% +$15.2K ﹤0.01% 1143
2024
Q1 		$29.1K Hold
628
– – ﹤0.01% 1119
2023
Q4 		$42.5K Hold
628
– – ﹤0.01% 1079
2023
Q3 		$45.5K Hold
628
– – ﹤0.01% 1026
2023
Q2 		$46.7K Hold
628
– – ﹤0.01% 1069
2023
Q1 		$33.4K Sell
628
-155
-20% -$9.82K ﹤0.01% 1048
2022
Q4 		$52.9K Sell
783
-1,109
-59% -$102K ﹤0.01% 1033
2022
Q3 		$236K Hold
1,892
– – ﹤0.01% 990
2022
Q2 		$180K Sell
1,892
-138
-7% -$16.8K ﹤0.01% 1144
2022
Q1 		$327K Hold
2,030
– – ﹤0.01% 1010
2021
Q4 		$675K Buy
+2,030
New +$964K ﹤0.01% 775

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return